Mendelian mutations, common risk factors, and ? more recently ? rare risk-associated variants have been identified in neurodegenerative dementia. Yet, a significant proportion of the heritability for Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD) remains unexplained, strongly suggesting that additional genetic risk factors await to be identified. Over the past 9 years, the Genetics Core has supported PPG investigators by 1) collecting and storing DNA and RNA samples from the entire PPG cohort; 2) providing genetic testing for known pathogenic causes of dementia and risk-associated variants; 3) contributing to the discovery of novel genes and novel risk-associated variants; 4) establishing an informatics platform to facilitate data sharing, storage and mining. In this renewal application, we propose to efficiently leverage this infrastructure and expertise, so as to expand the portfolio of genetic and genomics assays available to PPG investigators. We propose to continue sample collection and banking, to expand our sequencing and genotyping efforts to include all the known causes of Mendelian forms of dementia, the top disease susceptibility variants, and genome sequencing in a subset of the PPG cohort. These studies will contribute to a better patient characterization, and pave the way for subject selection and stratification based on genetic profiling in future clinical trials. Given the fundamental nature of genetic information in etiology and pathophysiology of FTD, this Core serves all of the projects in this program and is linked to the other PPG cores.

Public Health Relevance

The Genetics Core will collect biological samples from patients with dementia, and perform genetic and genomic analyses, in collaboration with other Cores and Projects part of this PPG, with the goal of discovering novel disease-causing or risk-associated variants and to facilitate the analysis of these genetic data in conjunction with other clinical and laboratory data, by providing an infrastructure for data storage, mining, and retrieval. These studies will contribute to better patient characterization, and pave the way for subject selection and stratification based on genetic profiling in future clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-19
Application #
9949603
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Miller, Zachary A; Rosenberg, Lynne; Santos-Santos, Miguel A et al. (2018) Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy. JAMA Neurol 75:728-737
Rojas, Julio C; Stephens, Melanie L; Rabinovici, Gil D et al. (2018) Multiproteinopathy, neurodegeneration and old age: a case study. Neurocase 24:1-6
Dijkstra, Anke A; Lin, Li-Chun; Nana, Alissa L et al. (2018) Von Economo Neurons and Fork Cells: A Neurochemical Signature Linked to Monoaminergic Function. Cereb Cortex 28:131-144
Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393
Erkkinen, Michael G; Zúñiga, Raquel Gutiérrez; Pardo, Cristóbal Carnero et al. (2018) Artistic Renaissance in Frontotemporal Dementia. JAMA 319:1304-1306
Schneider, Raphael; McKeever, Paul; Kim, TaeHyung et al. (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89:851-858
Ljubenkov, Peter A; Staffaroni, Adam M; Rojas, Julio C et al. (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol 5:1250-1263
La Joie, Renaud; Bejanin, Alexandre; Fagan, Anne M et al. (2018) Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282-e290
Kim, Eun-Joo; Brown, Jesse A; Deng, Jersey et al. (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960-2971
Henry, Maya L; Hubbard, H Isabel; Grasso, Stephanie M et al. (2018) Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain 141:1799-1814

Showing the most recent 10 out of 607 publications